Ductal Carcinoma In Situ Tied to Threefold Higher Risk for Death
Risk for dying from breast cancer remains elevated 15 years after initial diagnosis
Antibodies Decrease With Time After COVID-19 Symptom Onset
For all donors of convalescent plasma, drop seen in anti-RBD antibody levels from first to last donation
Atezolizumab Prolongs Survival in NSCLC With PD-L1 Expression
Overall survival longer than for chemotherapy in metastatic NSCLC with high PD-L1 expression
HPV Vaccination Tied to Decrease in Invasive Cervical Cancer Risk
Incidence rate ratio 0.12 among women vaccinated before age 17; 0.47 for those vaccinated at ages 17 to 30
September 2020 Briefing – Hematology & Oncology
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for September 2020. This roundup includes...
Hospital Admissions Not Related to COVID-19 Fell in Early 2020
From February to April 2020, drop >20 percent observed for all primary admission diagnoses
Review IDs Dietary Factors Linked to Lower CRC Incidence
Incidence up with frequent alcohol or meat consumption; no evidence of protective effect found for tea, coffee
Cancer Mortality Higher for U.S. Counties With Persistent Poverty
Counties with persistent poverty have higher overall, several type-specific cancer mortality rates
High-Risk Patients Not Aware of Needed Colonoscopy Intervals
Findings among patients with biopsy-confirmed advanced colorectal polyps
Private Health Plans Pay Hospitals 247 Percent of Medicare
Relative prices average 231, 267 percent of what Medicare would pay for inpatient, outpatient services
